Shoulder Innovations, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NYSE
Shoulder Innovations, Inc. announced its second quarter 2026 financial results, showcasing a 56% increase in net revenue to $17.2 million, driven by higher implant system sales and an expanding customer base.
NYSE
Shoulder Innovations, Inc. announced its first quarter 2026 financial results, showcasing a significant 64.9% increase in net revenue to $16.7 million, driven by higher implant system sales and an expanded customer base.
NYSE
Shoulder Innovations, Inc. reported a significant increase in net revenue for Q3 2025, driven by higher implant system sales, following its successful Initial Public Offering in August 2025.
NYSE
Shoulder Innovations, Inc. reported a 33.3% increase in net revenue for the second quarter of 2025, reaching $11.013 million, but also saw its net loss widen significantly to $19.196 million, influenced by fair value adjustments and public company transition costs, following its recent IPO.